Provided by Tiger Fintech (Singapore) Pte. Ltd.

Iovance Biotherapeutics, Inc.

1.79
-0.1400-7.25%
Pre-market: 1.800.0100+0.56%05:54 EDT
Volume:26.82M
Turnover:48.39M
Market Cap:597.74M
PE:-1.45
High:1.98
Open:1.98
Low:1.72
Close:1.93
Loading ...
May 30, 2023

Major Issues Report

Form 8-K - Current report
May 18, 2023

Major Issues Report

Form 8-K - Current report
May 10, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 10, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2023

Major Issues Report

8-K - Current report
Apr 24, 2023

Major Issues Report

8-K - Current report
Mar 27, 2023

Major Issues Report

8-K - Current report
Mar 10, 2023

Major Issues Report

8-K - Current report
Feb 28, 2023

Major Issues Report

8-K - Current report
Feb 28, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 17, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 06, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 27, 2023

Major Issues Report

8-K/A [Amend] - Current report
Jan 23, 2023

Major Issues Report

8-K - Current report
Jan 13, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 11, 2023

Major Issues Report

8-K - Current report
Dec 30, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals